KAPILCO
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Kapil Cotex To Consider Issuance Of Equity Shares Of Co By Way Of Preferential Issue
Oct 17 (Reuters) - Kapil Cotex Ltd KAPL.BO:
TO CONSIDER ISSUANCE OF EQUITY SHARES OF CO BY WAY OF PREFERENTIAL ISSUE
Source text for Eikon: ID:nBSE3x6rGM
Further company coverage: KAPL.BO
(([email protected];))
Oct 17 (Reuters) - Kapil Cotex Ltd KAPL.BO:
TO CONSIDER ISSUANCE OF EQUITY SHARES OF CO BY WAY OF PREFERENTIAL ISSUE
Source text for Eikon: ID:nBSE3x6rGM
Further company coverage: KAPL.BO
(([email protected];))
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Skybiotech Healthcar do?
Kapil Cotex Ltd. is a Mumbai-based company established in 1983, specializing in the manufacturing of yarn, linen, and fabrics, including grey knitted fabric for domestic and industrial purposes.
Who are the competitors of Skybiotech Healthcar?
Skybiotech Healthcar major competitors are Mohit Industries, Jet Knit, Swasti Vinayaka Syn., HP Cotton Textile, Southern Latex, Padam Cotton Yarns, Akshar Spintex. Market Cap of Skybiotech Healthcar is ₹40 Crs. While the median market cap of its peers are ₹42 Crs.
Is Skybiotech Healthcar financially stable compared to its competitors?
Skybiotech Healthcar seems to be less financially stable compared to its competitors. Altman Z score of Skybiotech Healthcar is 2.66 and is ranked 5 out of its 8 competitors.
Does Skybiotech Healthcar pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Skybiotech Healthcar latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Skybiotech Healthcar allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Skybiotech Healthcar balance sheet?
Balance sheet of Skybiotech Healthcar is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Skybiotech Healthcar improving?
The profit is oscillating. The profit of Skybiotech Healthcar is -₹2.37 Crs for Mar 2025, ₹1.54 Crs for Mar 2024 and -₹0.01 Crs for Mar 2023
Is the debt of Skybiotech Healthcar increasing or decreasing?
The net debt of Skybiotech Healthcar is decreasing. Latest net debt of Skybiotech Healthcar is ₹7.43 Crs as of Sep-25. This is less than Mar-25 when it was ₹7.74 Crs.
Is Skybiotech Healthcar stock expensive?
There is insufficient historical data to gauge this. Latest PE of Skybiotech Healthcar is 0
Has the share price of Skybiotech Healthcar grown faster than its competition?
Skybiotech Healthcar has given better returns compared to its competitors. Skybiotech Healthcar has grown at ~21.07% over the last 7yrs while peers have grown at a median rate of 14.87%
Is the promoter bullish about Skybiotech Healthcar?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Skybiotech Healthcar is 63.48% and last quarter promoter holding is 63.48%.
Are mutual funds buying/selling Skybiotech Healthcar?
There is Insufficient data to gauge this.
